Celgene announced a $9 billion cash buyout of Juno Therapeutics as it moves to cement its position as a key player in a new range of cancer therapies. Aleksandra Michalska reports.
01:15
00:17
02:26
01:32
00:59
00:55
01:06
01:02
00:47
00:28
01:01
02:19
00:52
00:33
01:15
00:33
01:04
01:05
00:25
00:52
02:22
00:47
01:22
01:08
01:01
02:59
01:49
00:49
02:23
00:50
02:26
01:53
00:45
01:09
00:55
01:27
00:49
00:45
01:03
01:34
01:15
00:17
02:26
00:47
00:28
00:52
00:33
01:05
00:25
01:59
01:34
00:33
00:40
00:28
00:26
01:23
00:43
01:24
01:21
00:30
01:02
01:28
01:57
01:03
02:00
03:34
01:30
00:51
02:02
00:51
02:07
02:05
01:36
01:23
02:26
01:11
00:28
01:38
01:00
01:23
01:18
01:09
01:23
01:26
01:35
01:07
02:52
05:07
01:11
01:42
01:55
01:29
00:59
00:49
00:57
01:41
02:09
01:36
00:48
01:00